GSK confirmed this morning that the disappointing readout from the DREAMM-3 trial of multiple myeloma therapy Blenrep reported earlier this month means that it will take the drug off the US market.

"Old-school lifters swore by paused reps because they eliminate the stretch reflex," says Everett Miner, NASM -CPT. "Instead of bouncing out of the bottom, you pause long enough that your muscles have ...